Published Paper Details:

Fluroquinolone antibiotic moxifloxacin is used to treat a variety of bacterial illness. A brand-new fluroquinolone antibiotic, moxifloxacin has a wide rang of activity against both Gram-positive and Gram-negative bacteria. when compared to ciprofloxacin, it exhibits better activity against Gram-positive species (such as staphylococci, steptococci, and enterococci) and anarobes, including penicillin-resistant sreptococcus pneumoniae. review of moxifloxacin activities, pharmaceutical kinetic, pharmacodynamics, efficacy, safety, medication interaction, dose, and administration A fluoroquinolone antibiotic called moxifloxacin is used to treat infection such as pneumonia, conjunctivitis, endocarditis, tuberculosis, sinusitis, the respiratory system, pelvic inflammatory disease, the skin and the intra-abdominal activity. Although most studies of its safety profile are good, others have quetioned iit because of infrequent but ptentially deadly toxicity (such as hepatic, cardiac, or cutaneous responses). Acute exacerbations of community-acquired pneumonia caused by pneumococcal (CAP) were observed in studies performed in patients